rapt.com (RAPT) - Dhuwit awis perusahaan

Simbol resmi perusahaan RAPT Therapeutics, Inc. (RAPT)

RAPT Therapeutics, Inc. (RAPT) develops selective molecules for the targeted suppression of allergic reactions without systemic immune suppression. The current cash position demonstrates the financial stability of the company, whose success depends on biological trials rather than economic cycles; this metric has reached 0.10. Business prospects rely on the development of innovative oral therapies for tumors and inflammation.

rapt.com - Gunggung dana dhuwit perusahaan RAPT (periode 04.07.2022 - 14.03.2026)

Ringkesan rincian data analitis RAPT Therapeutics Inc. (RAPT)

Pambiji fundamental:rapt.com
Produk merek RAPT Therapeutics

This indicator captures the organization's immediate liquidity, allowing for the differentiation of operational expenses from critical capital outflows. For RAPT Therapeutics, Inc. (RAPT), with its costly molecular platforms, the analysis of cash balances confirms the ability to fund the closed clinical circuit. The dynamics of these funds determine the autonomy horizon for immuno-pharmaceutical developments without the need for emergency debt financing. A stable level of reserves guarantees the company's resilience in the face of high costs.

Analisis perusahaan pesaing

Volume dana dhuwit perusahaan ARGX|BioNTech - Dhuwit awis lan setara dhuwit awis perusahaan|Volume dana dhuwit perusahaan ABVX (abivax.com)|Sisa dhuwit perusahaan ADMA|Protagonist Therapeutics, Inc. - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Immunovant, Inc.|KNSA: Volume dana dhuwit perusahaan|GRFS - Aset likuid perusahaan|ADPT (Adaptive Biotechnologies Inc.) - Volume dana dhuwit perusahaan|CLDX: Sisa dhuwit perusahaan|Dana dhuwit perusahaan Aurinia Pharmaceuticals Inc. (AUPH)|Dana dhuwit perusahaan BCRX (BioCryst Pharmaceuticals Inc)|Volume dana dhuwit perusahaan VERA (Vera Corp)|Gunggung dana dhuwit perusahaan DNTH (Dianthus Therapeutics)|PHVS - Dana dhuwit perusahaan|ABCL: Dana dhuwit perusahaan|TRML: Volume dana dhuwit perusahaan|Dhuwit awis perusahaan Precigen, Inc.|Dhuwit awis perusahaan PHAR|Nektar Therapeutics - Total volume dana dhuwit perusahaan|Dana dhuwit perusahaan Upstream Bio Corp (UPB)|Dhuwit awis perusahaan Zenas Biopharma ZBIO|Dana dhuwit perusahaan Immunome Bio IMNM|GOSS: Dhuwit awis lan setara dhuwit awis perusahaan|kalvista.com - Volume dana dhuwit perusahaan|SEPN (septerna.com) - Dhuwit awis lan setara dhuwit awis perusahaan|PVLA (Pieris Pharmaceuticals) - Dhuwit awis perusahaan|Savara - Sisa dhuwit perusahaan|RIGL (Rigel Corp) - Volume dana dhuwit perusahaan|Volume dana dhuwit perusahaan AnaptysBio Corp|Dana dhuwit perusahaan astriatx.com (ATXS)|Dhuwit awis perusahaan enGene ENGN|Volume dana dhuwit perusahaan JBIO (Aerovate Therapeutics Inc)|Aset likuid perusahaan Aclaris Therapeutics, Inc. (ACRS)|KYTX - Dana dhuwit perusahaan|Aset likuid perusahaan Tiziana Life Sciences TLSA|CABA: Volume dana dhuwit perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan VTYX|Dhuwit awis perusahaan THTX|Volume dana dhuwit perusahaan Avalo Therapeutics Inc.|Dana dhuwit perusahaan Eledon (ELDN)|Volume dana dhuwit perusahaan Agenus Inc (AGEN)|Volume dana dhuwit perusahaan CLYM (climbbio.com)|ZURA - Dhuwit awis perusahaan|atyrpharma.com - Volume dana dhuwit perusahaan|ADAG (adagene.com) - Dhuwit awis lan setara dhuwit awis perusahaan|IMA (Ikena Oncology) - Dhuwit awis perusahaan|Dhuwit awis perusahaan Shattuck Labs Inc|EQ (Equillium Inc) - Volume dana dhuwit perusahaan|CNTB: Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan IMUX|ATRA (Atara Biotherapeutics, Inc.) - Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan IFRX (inflarx.de)|X4 Pharmaceuticals - Dana dhuwit perusahaan|Adicet Bio, Inc. - Volume dana dhuwit perusahaan|CELU (celularity.com) - Dhuwit awis lan setara dhuwit awis perusahaan|INMB: Volume dana dhuwit perusahaan|Barinthus Biotherapeutics PLC (BRNS) - Volume dana dhuwit perusahaan|Dana dhuwit perusahaan Kezar Life Sciences|Dhuwit awis perusahaan SAB Biotherapeutics (SABS)|Dana dhuwit perusahaan Akari Therapeutics Plc (AKTX)|Dhuwit awis perusahaan Enlivex Therapeutics, Ltd. ENLV|Q32 Bio Inc. - Dhuwit awis perusahaan|GeoVax Labs (GOVX) - Cadangan dhuwit perusahaan|edesabiotech.com - Volume dana dhuwit perusahaan|Aset likuid perusahaan iBio Corp IBIO|CARM: Volume dana dhuwit perusahaan|xtlbio.com (XTLB) - Volume dana dhuwit perusahaan|BOLT (Bolt Biotherapeutics) - Volume dana dhuwit perusahaan|Dhuwit awis perusahaan HCW Biologics (HCWB)|Dhuwit awis perusahaan APVO (Aptevo Therapeutics)|AIM - Cadangan dhuwit perusahaan|Aditxt - Dhuwit awis perusahaan|Posisi dhuwit perusahaan gribio.com|XRTX: Dhuwit awis perusahaan|Sisa dhuwit perusahaan HIND (Vyome Holdings)|REVB (Revelation Bio) - Dhuwit awis perusahaan|Indaptus Corp (INDP) - Volume dana dhuwit perusahaan|Dana dhuwit perusahaan scinai.com|Dhuwit awis perusahaan CalciMedica, Inc. (CALI)|Dana dhuwit perusahaan Affimed NV (AFMD)|Dana dhuwit perusahaan ALLK (Allakos Inc)|Dana dhuwit perusahaan HOOKIPA Pharma, Inc. HOOK|Aset likuid perusahaan IGM Bio (IGMS)|iTeos Pharma - Volume dana dhuwit perusahaan|Aset likuid perusahaan oceanbiomedical.com OCEA|TC BioPharm (TCBP) - Dana dhuwit perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan THRD